- Global Pharma News & Resources

Global RNA Analysis Market Research Report 2021: $25.48 Bn Potential Opportunities in Single Cell Transcriptomics and Associated Big Data & Advances In Sequencing Technologies -

DUBLIN--(BUSINESS WIRE)--The "RNA Analysis Market Size, Share & Trends Analysis Report by Product (Instruments, Services), by Technology (qPCR, Microarray), by End-use (CROs, Hospitals & Clinics), by Application, and Segment Forecasts, 2021-2028" report has been added to's offering.

The global RNA analysis market size is anticipated to reach USD 25.48 billion by 2028, expanding at a CAGR of 13.44%

Technological advancements in this market can be attributed to the increasing applications of transcriptome sequencing into life science for capturing polyadenylated RNA. For instance, in July 2021, a Lithuanian team is developing a droplet-based technique for simultaneous mRNA and microRNA capture and sequencing in a single cell. The research is backed by European Union with USD 174,000 Horizon 2020 research grant.

Such initiatives are anticipated to accelerate market growth in the near future. Ribonucleic acid transcriptome analysis enables the researchers to analyze the position of genes as well as the functional patterns of a specific gene in an organism. The method assists in evaluating every transcript's changing behavior at the development stage and assesses all the elements of a transcript, including messenger ribonucleic acid, non-coding ribonucleic acid, and micro ribonucleic acid, for identifying the transcriptional structure of genes.

The growing need for analyzing a huge number of genes to understand the gene-to-drug interactions is anticipated to enhance the application of transcriptomics technologies in discovery applications and drug development. For instance, transcriptome profiles of COVID-19 patients have been analyzed to examine the disease prognosis and management. Collaborations between research institutes for the use of transcriptomics in various applications would drive market growth.

For instance, in October 2021, National Cancer Institute and Caris Precision Oncology Alliance collaborated for medicine research initiatives. As a part of the partnership, Caris will offer detailed molecular insights across RNA (transcriptome), DNA (genome), and protein (proteome). North America was the top revenue-generating region in 2020 owing to the high investments in pharmaceutical and biotechnology research by corporations.

For instance, in September 2021, Illumina invested in seven genomics-based startups as part of the international accelerator program. This program will give startups access to Illumina's lab space, sequencing systems, and reagents.

Asia Pacific is projected to register the fastest CAGR from 2021 to 2028 owing to the low-cost manufacturing services in the region that provide lucrative growth opportunities for the manufacturers.

RNA Analysis Market Report Highlights

  • Real-Time- PCR (qPCR) accounted for the major market share in the technology segment in 2020 and is estimated to continue the trend during the forecast period
  • The transcriptome sequencing technology showcases relatively high CAGR during the forecasted period
  • The kits and reagents segment held the highest revenue share in 2020 owing to a high utilization rate of consumables during transcriptomic studies
  • Microarrays have gained significant traction in recent years, as it is becoming a common approach for the measurement of thousands of messenger nucleic acid transcripts for gene expression
  • The infectious diseases and pathogenesis segment accounted for the largest market share in 2020 and is anticipated to have a similar trend during the forecasted period
  • Government institutes & academic centers dominated the end-user segment due to the increasing number of institutes and centers leveraging high throughput technologies for the effective and efficient process of ribonucleic acid analysis

Market Dynamics

Market Driver Analysis

  • Transcriptomics In Cancer Personalized/Precision Medicine
  • Rising Diagnostic Utility Of Transcriptomics Technologies
  • Advent Of Novel Approaches For Understanding Gene Expression At RNA Level

Market Restraint Analysis

  • Higher Cost Of Research And Developments
  • High Cost Associated With Platforms

Market Opportunity Analysis

  • Single Cell Transcriptomics And Associated Big Data
  • Advances In Sequencing Technologies

Market Challenge Analysis

  • Data Management In Transcriptomics Research
  • Lack Of Effective Bioinformatics Tools

Business Environment Analysis

  • SWOT Analysis; By factor (Political & Legal, Economic and Technological)
  • Porter's Five Forces Analysis

Competitive Analysis

  • Recent Developments & Impact Analysis, by Key Market Participants
  • Strategy Framework
  • Market Participant Categorization
  • Major Deals & Strategic Alliances Analysis
  • Mergers and acquisitions
  • Partnerships
  • Agreements
  • Synergies, Collaborations, and other initiatives
  • Market Entry Strategies

Companies Mentioned

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • F.Hoffman-La Roche Ltd.
  • Thermo Fisher Scientific, INC.
  • Eurofins Scientific
  • Merck kgaA
  • Pacific Bioscience of California, inc.
  • Affymetrix inc.

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 06-Jan-2022